 | • レポートコード：B-MOR-040956 • 出版社/出版日：Mordor Intelligence / 2018年2月 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：食品・飲料 |
| Single User（1名様用） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User（7名様用） | ￥666,000 (USD4,500) | ▷ お問い合わせ |
| Corporate User | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、藻類由来のオメガ3成分の世界市場について調べ、藻類由来のオメガ3成分の世界規模、市場動向、市場環境、タイプ別（エイコサペンタエン酸（EPA）、ドコサヘキサエン酸（DHA））分析、濃度別（高、中、低）分析、純度・品質タイプ別分析、用途別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・藻類由来のオメガ3成分の世界市場インサイト ・藻類由来のオメガ3成分の世界市場環境 ・藻類由来のオメガ3成分の世界市場動向 ・藻類由来のオメガ3成分の世界市場規模 ・藻類由来のオメガ3成分の世界市場規模：タイプ別（エイコサペンタエン酸（EPA）、ドコサヘキサエン酸（DHA）） ・藻類由来のオメガ3成分の世界市場規模：濃度別（高、中、低） ・藻類由来のオメガ3成分の世界市場規模：純度・品質タイプ別 ・藻類由来のオメガ3成分の世界市場規模：用途別 ・藻類由来のオメガ3成分の世界市場：地域別市場規模・分析 ・藻類由来のオメガ3成分の北米市場規模・予測 ・藻類由来のオメガ3成分のアメリカ市場規模・予測 ・藻類由来のオメガ3成分のヨーロッパ市場規模・予測 ・藻類由来のオメガ3成分のアジア市場規模・予測 ・藻類由来のオメガ3成分の日本市場規模・予測 ・藻類由来のオメガ3成分の中国市場規模・予測 ・藻類由来のオメガ3成分のインド市場規模・予測 ・関連企業情報・競争状況 |
The global algae omega 3 ingredient market records a revenue of USD 431.5 million in 2016 and is expected to grow at a CAGR of 11.5 % during the forecast period of 2018 – 2023. Algae as a source accounts for 18% of the global Omega 3 Ingredient market. The market is highly fragmented with the regional domestic players and the international players.
Strong Demand in Infant Formula Products
The demand for algae omega 3 is growing at a faster rate in infant food fortification as it provides the same benefit that of fish oil, but it has no off odor or taste. Omega 3 obtained from algae is considered as more bioavailable and sustainable for production which is highly required at present time, where overfishing is a major problem. Another benefit associated with algae Omega 3 is, it is vegan. Moreover, the product quality of algae Omega 3 is superior as compared to fish oil because it is free from any toxic pollutants, and possesses high purity in terms of form of fatty acid, and off sensory properties. The major restraining factor with market is the high cost of product due to higher downstream processing cost. However, with passage of time due to technological advancement, the market can be highly competitive.
High Adoption of Docosahexanoic acid (DHA)
Commercially, there are two types of essential Omega 3 fatty acid derived from algae: Eicosapentanoic acid (EPA) and Docosahexanoic acid (DHA). DHA holds the largest share in the market due to its high demand in infant formula products and legal recommendations on it. EPA is the fastest growing market supported by the various health benefits, which has increased its importance in drug formulation.
By concentration type, market is divided into high concentrated, concentrated and low concentrated product. Currently, low concentrated and concentrated algae ingredient are capturing the market demand. Dietary supplement holds the largest share in the algae omega 3 ingredient market followed by infant formula application. Growing awareness among consumers regarding the daily dosage of Omega 3 has focused the demand of high concentrated products.
The use of algae Omega 3 ingredient in dietary supplements accounts for the largest share of 53.5% in 2016. Increasing demand by pharmaceutical companies for Omega 3 oils sourced from algae is driving its demand in pharmaceuticals. Animal nutrition is another major growing segment for the market due to increased health concern among pet owners.
North America to Dominate the Market Growth
North America followed by Europe dominates the market. Increased consumption of Omega 3 supplements in countries like U.S is driving the market in developed regions. Asia- Pacific is the fastest growing region due to growing fortified food market and increased consumer awareness. Japan and China are the significant market in Asia- Pacific captured with major domestic players. South America is another growing market for algae omega 3 ingredient market driven by the high consumption of fortified products.
Key Developments in the Market
• January 2018: Startup Triton Algae is bringing healthy and safe non GMO, and vegan algea powder rich in omega – 3, 6, and 9 fatty acids, vitamin A/ Betacarotene and iron. This is an excellent source of high protein.
• September 2017: Nordic Naturals® Introduces Five New Children’s Products. The new products offer concentrated, triglyceride-form omega-3 fish oil in age-appropriate formulations for cognition, learning and attention, mood health, and more, plus a kid-friendly, fast-melt probiotic powder.
Major Key Players: DSM NUTRITIONAL PRODUCTS, BIOPROCESS ALGAE, Llc, NEPTUNE WELLNESS SOLUTIONS, SOURCE-OMEGA, QUALITAS HEALTH, NORDIC NATURALS, ADM, ALGAECYTES, SIMRIS ALG, ALGISYS, POLARIS, TERRAVIA (SOLAZYME), BIOCEUTICALS
Reasons to Purchase this Report
• Analyzing outlook of the market with the recent trends and Porter’s five forces analysis
• Market dynamics which essentially consider the factors which are impelling the present market scenario along with growth opportunities of the market in the years to come
• Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects
• Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market
• Competitive landscape involving the market share of major players along with the key strategies adopted for development in the past five years
• Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis and strategies employed by the major market players
• 3 months analyst support along with the Market Estimate sheet in excel.
Customization of the Report
• Value chain analysis
• Consumer behavior analysis in country level
1. Introduction
1.1 Key Deliverables of the s=Study
1.2 Study Assumptions
1.3 Market Definition
2. Research Approach and Methodology
2.1 Introduction
2.2 Research Design
2.3 Study Timeline
2.4 Study Phases
2.4.1 Secondary Research
2.4.2 Discussion Guide
2.4.3 Market Engineering & Econometric Modelling
2.4.4 Expert Validation
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.1.1 Increased Demand for Infant Formula Products in Developing Region Such as China
3.1.1.2 Sustainable Source of Omega-3 Fatty Acid Suitable for Vegetarian Label
3.1.1.3 Superior Product Quality and Best Alternative for Fish Oil Omega-3
3.1.2 Restraints
3.1.2.1 High Downstream Processing Cost Which Increases the Price
3.1.2.2 Low Consumer Awareness
3.1.3 Opportunities
3.1.3.1 Growing Demand for Algae EPA in Drug Application
3.1.3.2 High Demand for Premium Quality Omega-3 Products in Developed Regions
3.1.4 Porter’s Five Forces Analysis
3.1.4.1 Bargaining Power of Suppliers
3.1.4.2 Bargaining Power of Buyers
3.1.4.3 Threat of New Entrants
3.1.4.4 Threat of Substitute Products and Services
3.1.4.5 Degree of Competition
4. Market Segmentation
4.1 By Type
4.1.1 Eicosapentanoic Acid (EPA)
4.1.2 Docosahexanoic a=Acid (DHA)
4.2 By Concentration Type
4.2.1 High-Concentrated
4.2.2 Concentrated
4.2.3 Low-Concentrated
4.3 By Purity/Quality Type
4.3.1 Premium
4.3.2 Others
4.4 By Application
4.4.1 Food & Beverages
4.4.1.1 Infant Formula
4.4.1.2 Fortified Food & Beverages
4.4.2 Dietary Supplement
4.4.3 Pharmaceuticals
4.4.4 Animal Nutrition
4.5 By Geography
4.5.1 North America
4.5.1.1 United States
4.5.1.2 Canada
4.5.1.3 Mexico
4.5.1.4 Others
4.5.2 Europe
4.5.2.1 Spain
4.5.2.2 UK
4.5.2.3 France
4.5.2.4 Germany
4.5.2.5 Russia
4.5.2.6 Italy
4.5.2.7 Others
4.5.3 Asia-Pacific
4.5.3.1 China
4.5.3.2 India
4.5.3.3 Japan
4.5.3.4 Australia
4.5.3.5 Others
4.5.4 South America
4.5.4.1 Brazil
4.5.4.2 Argentina
4.5.4.3 Others
4.5.5 Africa
4.5.5.1 South Africa
4.5.5.2 Others
5. Competitive Landscape
5.1 Strategies Adopted by Key Players
5.2 Most Active Companies in the Past Five Years
5.3 Market Share Analysis
6. Company Profiles
6.1 DSM NUTRITIONAL PRODUCTS
6.2 BIOPROCESS ALGAE, LLC
6.3 NEPTUNE WELLNESS SOLUTIONS (Biogroga)
6.4 SOURCE-OMEGA
6.5 QUALITAS HEALTH
6.6 NORDIC NATURALS
6.7 ADM
6.8 ALGAECYTES
6.9 SIMRIS ALG
6.10 Algisys
6.11 Polaris
6.12 TerraVia (Solazyme)
6.13 Xiamen Huison Biotech
6.14 Nature’s Way (Ascenta Health)
6.15 BIOCEUTICALS
6.16 SYNTHETIC GENOMICS
7. Appendix
7.1 Disclaimer
7.2 Sources